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Dual mechanism of angiotensin II inhibits ANP-induced
mesangial cGMP accumulation
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Dual mechanism of angiotensin II inhibits ANP-induced mesangial
cGMP accumulation. To evaluate an interaction between vasoconstric-
tive (Ang II)' and vasodilating (ANP) peptides, we examined the effect
of Ang II on AN P-induced accumulation of cGMP in cultured glomer-
ular mesangial cells. ANP rapidly increased intracellular cGMP levels,
with a peak stimulation at one minute in the absence of IBMX and at ten
minutes in the presence of IBMX. The ANP-induced cGMP accumu-
lation was significantly inhibited when the cells were treated with Ang
H simultaneously with ANP for one minute in the absence of IBMX.
This inhibitory effect of Ang 11 was completely abolished by IBMX and
significantly reduced in calcium-free media or by W7, but not affected
by H7. Similar inhibitory effect was observed when cells were treated
with A23 187 but not with TPA for one minute. In the presence of
IBMX, Ang II inhibited ANP-induced cGMP accumulation when cells
were treated with Ang II for 15 minutes prior to the stimulation by
ANP. This inhibition by Ang II was blocked by H7. ANP-induced
increase in particulate guanylate cyclase activity was significantly
reduced in the cells treated with Ang 11 or TPA. This reduction of
enzyme activity was also prevented by H7. These results indicate that
Ang LI inhibits ANP-induced cGMP accumulation in cultured glomer-
ular mesangial cells through at least two mechanisms; one is the
activation of calcium-dependent, calmodulin-stimulated cyclic nucleo-
tide phosphodiesterase in the initial phase, and the other is the
inhibition of guanylate cyclase resulting from protein kinase C activa-
tion in the maintenance phase.
Glomerular mesangial cells may be the cells of importance in
the regulation of glomerular filtration rates through their con-
tractility. Mesangial cells have receptors specific to various
vasoconstrictive substances such as angiotensin II (Ang II) [I,
2], vasopressin [3] and endothelin [4], and to vasodilating
substances such as atrial natriuretic peptide (ANP) [5]. Stimu-
lation by these substances will result in contraction or relax-
ation of mesangial cells [6, 71, leading to the change in the
capillary surface area necessary to glomerular filtration [8].
Contractile state of mesangial cells could be, therefore, regu-
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lated in a balance of the effects among these vasoactive sub-
stances. It is, thus, important to evaluate a possible interaction
among these substances in glomerular mesangial cells.
It has been recently reported that ANP and prostaglandin E2
prevent the contractile effect of Ang II on cultured mesangial
cells [9—Il]. Moreover, ANP has been reported to inhibit Ang
II- or vasopressin-induced Ca2 mobilization and contraction of
cultured mesangial cells [12—14]. Although, in cultured vascular
smooth muscle cells, Ang II has been reported to inhibit
ANP-induced intracellular cyclic GMP (cGMP) accumulation
[15], the effect of Ang II on the action of ANP in glomerular
mesangial cells are still unclear. We, therefore, examined the
effect of Ang II on the action of ANP and the mechanism of it
in cultured mesangial cells. Since ANP has been reported to
generate cGMP, a possible second messenger of ANP, in
cultured mesangial cells [5, 7, 9, 14], intracellular cGMP was
measured as a marker of ANP action.
Methods
Rat ANP (1-28) and Ang II were obtained from Peptide
Institute (Suita, Japan). TPA, W7 and H7 were purchased from
Biochemical Industry (Tokyo, Japan), A23187 from Calbio-
chemical (La Jolla, California, USA), and cGMP assay kit from
Yamasa Co. (Chiba, Japan). Fetal bovine serum was purchased
from Gibco (Grand Island, New York, USA). All other reagents
were of chemical grade and purchased from standard suppliers.
Mesangial cell culture
Glomeruli were isolated from Sprague-Dawley rats weighing
50 to 100 g by sieving with stainless steel and nylon meshes
under sterile conditions as previously reported [16]. Isolated
glomeruli were then cultured in RPMI 1640 medium containing
20% fetal bovine serum and antibiotics. Cultured cells were
identified as mesangial cells by following evidences as previ-
ously described [17, 181: 1.) the cells survived in a medium
containing D-valine substituted for L-valine, indicating the
existence of D-aniino acid oxidase; 2.) they were resistant to
puromycin aminonucleoside (10 sg/mI) but susceptible to mito-
mycin C (10 /LgIml); 3.) they possessed a large number of
intracellular actin bundles stained by peroxidase-conjugated
heavy melo-myosin; 4.) they had receptors specific to Ang II
and contracted in response to Ang II. The cells at 5 to 15
passages were grown on 35 mm six-well plates and were used
for the experiment after confluency. Prior to the experiment,
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'25-Ang II binding was measured in each passage and the cells
having specific binding at least ten times higher than non-
specific binding were used.
Experimental design and determination of intracellular cGMP
The confluent cells were rinsed three times with a buffer
containing 120 m NaCI, 5 mr.i KCI, 1 mri CaCI2, 1 mtvt MgCl2,
20 mri HEPES-Tris, pH 7.4. After incubating the cells with the
same buffer at 37°C for 15 minutes, various compounds were
introduced.
For the short term experiment, cells were incubated with Ang
II simultaneously with ANP for one minute. IBMX, W7, or H7
was added two minutes, 20 minutes, or 20 minutes prior to the
addition of Ang II, respectively. To examine the role of
extracellular calcium, cells were exposed to a buffer without
calcium and with 2 mrs EGTA for 15 minutes before the
addition of Ang II. A23187 or TPA was introduced simulta-
neously with ANP similar to Ang II.
For more prolonged experiment, cells were incubated with
Ang II or TPA for 15 minutes before the addition of ANP. To
prevent the degradation of Ang II, ACTH (50 tg/ml) was used
[19]. IBMX or H7 was added two minutes or 20 minutes prior to
the addition of Ang II or TPA.
The reaction was terminated by aspirating the buffer and
adding 0.5 ml ice-cold 6% trichloroacetic acid (TCA). The cells
were then incubated with TCA for 20 minutes on ice, scraped
off the plate, sonicated and stored at —20°C. For the determi-
nation of cGMP, the sample was thawed and centrifuged at 2000
x g for 15 minutes at 4°C. The supernatant was then extracted
five times with two volume of ethylether saturated with water
and lyophilized. The lyophilized sample was resuspended in 500
.d water and 100 d aliquots were taken for succinylation.
Concentrations of succinylated cGMP were determined by
radioimmunoassay [20]. Cellular protein was determined in the
pellet by the method of Lowry et al [21]. In some experiments,
incubation buffer was collected and lyophilized, and concentra-
tions of cGMP were determined.
Determination of particulate guanylate cyclase activity
The activity of particulate guanylate cyclase of cultured
mesangial cells was measured using the method previously
described [22, 231 with slight modification. The confluent
mesangial cells were incubated with Ang II or TPA for 15
minutes at 37°C as described above. The cells were then washed
with a cold solution of 50 mrt Tris-HCI, pH 7.6, containing 150
mM NaCI, scraped off the dishes, and centrifuged at 500 x g for
five minutes at 4°C. The cell pellet was resuspended in 1 ml of
50 mM Tris-HC1, pH 7.6, containing 1 mri EDTA, 0.2 mM
phenylmethylsulfonyl fluoride, and 0.01% bacitracin (buffer A),
sonicated for 15 seconds, and centrifuged at 100,000 x g for one
hour at 4°C. The pellet was resuspended in buffer A, sonicated,
and centrifuged again. The pellet was resuspended in 0.5 ml of
50 mM Tris-HCI, pH 7.6, and used for the assay of guanylate
cyclase activity. An aliquot was taken for the determination of
protein by the method of Lowry et al. [211.
A 10 p1 aliquot of the particulate fraction was added to a tube
containing 80 1td of a reaction mixture. A reaction mixture
consists of, in a final concentration, 50 mrt Tris-HCI, pH 7.6, 1
mM IBMX, 15 mrvs creatine phosphate, and 20 g creatine
phosphokinase with or without ANP. The reaction was started
ANP, M Ang II, M
Fig. I. Effect of ANP on intracellular cGMP accumulation in cultured
mesangial cells (A) in the absence (O—O) or presence (S 5) of
1O M Ang II and (B) dose-dependent inhibition of ANP (1O-
M)-induced cellular cGMP accumulation by Ang II. Cells (at passage
10) were exposed to ANP or ANP plus Ang H for one minute. Values
are mean SEM (N — 3). < 0.01 vs. ANP alone.
by adding 10 ril of a solution containing 10 mM GTP and 40 mM
MnCI2, After the incubation at 37°C for 10 minutes, the reaction
was stopped by the addition of 0.9 ml of 50 m sodium acetate
followed by heating at 90°C for three minutes. Heated incuba-
tion mixture was centrifuged at 2000 x g for 20 minutes and
supernatant fraction was used for cGMP radioimmunoassay.
Statistical analysis
Comparisons between two groups were done by Student's
unpaired t-test. Comparisons among three or more groups were
done by one-way analysis of variance (ANOVA) followed by
Scheffe's test to evaluate statistical significance between any
two groups.
Results
Time course of ANP-induced cGMP accutnulation
Intracellular cGMP levels before and 15 seconds, 30 seconds,
1 minute, 2 minutes, and 5 minutes after addition of ANP were
0.43 0.08, 36.2 1.09,57.8 1.42, 159.9 22.3, 150.2 5.8,
and 114.4 23.7 pmol/mg protein (mean SEM,N = 6 to 12),
respectively, with a peak at one minute in the absence of
IBMX. In the presence of IBMX, intracellular cGMP levels
before and one minute, two minutes, five minutes, 10 minutes,
and 15 minutes after addition of ANP were 14.0 0.78, 504.5
22.7, 794.5 18.4, 1323.5 49.5, 1377.1 37.8, and 1303.7
37.2 pmollmg protein (mean SEM, n = 6), respectively. The
cells were, therefore, exposed to ANP for one minute in the
short-term experiments and for one or ten minutes for pro-
longed time experiments.
Short-term effect of Ang II on ANP-induced cGMP
accumulation
ANP increased intracellular cGMP levels in a dose dependent
fashion as shown in Figure IA. Simultaneous exposure of the
cells to both ANP and Ang II for one minute resulted in
significant suppression of intracellular cGMP, as shown in
Figure IA. This inhibitory effect of Ang II on ANP-induced
cGMP accumulation was observed in a dose dependent manner
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of Ang II with a half-maximum inhibition at 2 x i0 M (Fig.
1B). The basal value of intracellular cGMP (0.43 0.04
pmol/mg prot, mean SEM, N 6) was slightly reduced by
l0— M Ang 11(0.35 0.02 pmol/mg prot), though it was not
statistically significant. In the incubation buffer, cGMP was not
detected without the stimulation of ANP. The value of cGMP in
the incubation buffer after stimulation of ANP (0.136 0.005
pmol/mg cell prot, mean SEM, N = 6) was significantly (P <
0.01) reduced by co-incubation with ANP and Ang 11(0.108
0.004 pmol/mg cell prot).
To examine whether the inhibitory effect of Ang II is specific
to ANP-induced cGMP accumulation, the effect of Ang II on
cGMP accumulation induced by nitroprusside (NP), an activa-
tor of soluble guanylate cyclase, was studied. Increase in
cellular cGMP accumulation induced by NP (92.2 5.4
pmol/mg prot, mean SEM, N = 3) was significantly (P < 0.01)
suppressed by Ang 11(11.5 0.8 pmol/mg prot).
The mechanism of the inhibitory effect of Ang II on ANP-
induced cGMP accumulation was examined. As shown in
Figure 2, pretreatment of the cells with 3-isobutyl-l-methyl-
xanthine (IBMX), an inhibitor of cyclic nucleotide phosphodi-
esterase, for two minutes prior to the addition of ANP and Ang
II dose-dependently prevented the inhibitory effect of Ang II on
ANP-induced cGMP accumulation. In the concentrations of
IBMX more than 1 m, the inhibitory effect of Ang II was
completely abolished. When the cells were incubated in a buffer
free from calcium ions, ANP-induced intracellular cGMP accu-
mulation increased significantly (Fig. 3), suggesting that cyclic
nucleotide phosphodiesterase was calcium dependent. The in-
hibitory effect of Ang II on ANP-induced cGMP accumulation
in the cells incubated in a calcium-free buffer (24.6% inhibition)
was significantly reduced compared with that in the cells
incubated in a buffer with 1 m calcium (51.5% inhibition; Fig.
3). Moreover, treatment of the cells with W7, an inhibitor of
calmodulin [24], for 20 minutes prior to the addition of ANP and
Ang II reduced the inhibitory effect of Ang II on AN P-induced
cGMP accumulation (% inhibition at 0, 1O, 5 x l0, and
0
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Fig. 4. Effect of W7 on ANP-induced cellular cGMP accumulation in
the presence or absence of Ang II in cultured mesangial cells. Cells (at
passage 9) were exposed to various concentrations of W7 for 20 minutes
and then incubated with ANP (l0- M, EJ) or ANP plus Ang II (1O—
si, ) for one minute. Values are mean SEM (N = 6), *P < 0.05,
**p < 0.01 vs. values obtained by co-incubation with ANP and Ang II
without W7.
iO M W7 were 46.3%, 42.1%, 33.6%, and 16.7%, respective-
ly), although W7 at high concentrations (10—a M) inhibited
ANP-induced cGMP accumulation (Fig. 4). Furthermore,
A23 187, a calcium ionophore, could mimic the inhibitory effect
of Ang II on ANP-induced cGMP accumulation as shown in
Table I. However, H7, an inhibitor of protein kinase C [25],
failed to prevent the inhibitory effect of Ang II on ANP-induced
cGMP accumulation and TPA, an activator of protein kinase C,
could not mimic the action of Ang II when the cells were
exposed to TPA for one minute simultaneously with ANP
(Table 2).
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Fig. 2. Effect of IBMX on ANP-induced cellular cGMP accumulation
in the presence or absence of Ang II in cultured mesangial cells. Cells
(at passage 10) were first treated with various concentrations of IBMX
for two minutes and then incubated with ANP (l0 si) for one minute
in the presence () or absence (EJ) of Ang II (l0- M). Values are
mean SEM (N = 6). * <0.05, ** <0.01 vs. ANP alone in the same
concentrations of IBMX.
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Fig. 3. Effect of omission of extracellular calcium on ANP-induced
cellular cGMP accumulation in the presence or absence of Ang II in
cultured mesangial cells. Cells (at passage 8) were exposed to a buffer
containing 1 mM Ca2 or a buffer without Ca2 and with 2 msi EGTA
for 15 minutes and then incubated with ANP (10-v M) orANP plus Ang
II (10 si) for one minute. Values are mean SEM (N = 6). *P < 0.01
vs. corresponding values under 1 ms Ca2.
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Table 1. Effects of Ang II and A23 187 on ANP-induced cGMP
accumulation in cultured mesangial cells
Cellular cGMP
pmol/mg pro!
ANP i0 M 76.1 7.4
ANP l0- M + Ang H l0- M 32.6 2.6a
ANP l0- M + A23187 106 M 40.1 4.2a
ANP iO M 78.0 4.7
ANP io- M + H7 l0 M 74.8 1.7
ANP i0 M + ANG II l0 M 39.3 3.oa
ANP i0 M + ANG II l0 M 39.7 2.9a
+ H7 l0 M
ANP 1O M + TPA l0_6 M 79.4 6.5
When the cells were treated with Ang II for 15 minutes prior
to the addition of ANP, Ang II significantly inhibited ANP-
induced cGMP accumulation (Fig. 5). This prolonged effect of
Ang II was observed even in the presence of 1 mM IBMX (Fig.
5A). The degree of inhibition by Ang II was smaller than that
obtained when the cells were exposed to Ang II for one minute
simultaneously with ANP in the absence of IBMX, possibly due
to the degradation of Ang II although ACTH (SO g/ml) was
added to the buffer to prevent the degradation. The inhibitory
effect of Ang II on ANP-induced cGMP accumulation was
prevented by pretreatment of the cells with H7 (Fig. SB). When
the cells were treated with TPA for 15 minutes, ANP-induced
cGMP accumulation was significantly suppressed even in the
presence of IBMX (Fig. 5A) and this effect of TPA was also
prevented by pretreatment of the cells with H7 (Fig. SB).
Because in the presence of IBMX ANP-induced cGMP
accumulation reached to the maximum level at 10 minutes, the
effect of Ang II was further studied by incubating the cells with
ANP for 10 minutes in the presence of IBMX. As shown in
Figure 6, the treatment of the cells with Ang II for 10, 15, and
20 minutes prior to the addition of ANP significantly inhibited
ANP-induced cGMP accumulation.
Effect of Ang II on particulate guanylate cyclase
To know the mechanism of the prolonged effect of Ang II on
ANP-induced cGMP accumulation, the effect of Ang H on
particulate guanylate cyclase was examined. When the cells
were treated with Ang II for 15 minutes prior to the isolation of
particulate fractions, the activity of particulate guanylate cy-
clase after the stimulation of ANP was significantly inhibited
A
Cells (at passage 15) were incubated with ANP, ANP plus Ang 11 or
ANP plus A23 187 for one minute. Values are mean SEM (N = 6).
a P < 0.01 vs. ANP alone
Table 2. Effect of H7 on the action of Ang 11 and effect of TPA on
ANP-induced cGMP accumulation in cultured mesangial cells
Cellular cGMP
pmot/mg pro!
400
- 300
- 200
U
.2 100
6)0
400
300
E
200
100
0
IBMX 0mM 1mM
Cells (at passage 10) were exposed to ANP, ANP plus Ang 11 or ANP
plus TPA for one minute. Cells were treated with H7 for 20 minutes
prior to the addition of ANP or ANP plus Ang H. Values are mean
SEM (N = 6).
a P < 0.01 vs. ANP alone
Prolonged effect of Ang II on ANP-induced cGMP
accumulation 0
ANP ANP+AngII ANP+TPA
0 i0-H7(M) 0 iO 0 iO
Fig. 5. Prolonged effect of Ang II or TPA on ANP-induced cellular
cGMP accumulation in cultured mesangial cells in the presence or
absence of JBMX (A) and effect of H7 on inhibition of ANP-induced
cGMP accumulation by Ang II or TPA (B). In panel A, cells (at passage
6) were exposed to Ang II(l0- M, ), TPA(l06M, EJ)ora buffer
without these substances (EJ) for 15 minutes in the presence (1 mM) or
absence of IBMX and then incubated with ANP (l0 M) for one
minute. Values are mean SEM (N = 6). **< 0.01 vs. ANP alone. In
panel B, cells (at passage 7) were exposed first to H7 () for 20
minutes and then to Ang H (l0- M)or TPA (l0_6 M) for 15 minutes.
Cells were then incubated with ANP (10-v 54) for one minute. IBMX (1
mM) was used to inhibit phosphodiesterase. Values are mean 5EM (N
= 6). *p < 0.01 vs. ANP alone in the absence of H7; *D < 0.05, <
0.01 vs. ANP plus Ang 11 or ANP plus TPA in the absence of H7.
(Fig. 7A). The treatment of the cells with H7 prior to Ang II
could prevent the inhibitory effect of Ang II (Fig. 7A). Basal
activity of particulate guanylate cyclase in the cells treated with
Ang II was not different from that in the untreated cells but
significantly lower than that in the cells treated with H7.
Similarly to Ang II, the treatment of the cells with TPA
significantly inhibited ANP-stimulated activity of particulate
guanylate cyclase and H7 was able to prevent this inhibitory
effect of TPA (Fig. 7B).
Discussion
The present study was undertaken to examine the effect of
Ang II on ANP-induced intracellular cGMP accumulation in
cultured glomerular mesangial cells. The data clearly indicate
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Fig. 6. Time course of the prolonged inhibitory effect of Ang II on
A NP-induced cellular cGMP accumulation in cultured mesangial cells.
Cells (at passage 5) were first exposed to Ang H (10 M,S •) or the
vehicle (O-—-—O) for 0, 2, 10, 15, or 20 minutes as indicated in the
horizontal axis in the presence of IBMX, and then incubated with ANP
for 10 minutes. Values are mean 5EM (N = 4). *D < 0.01 vs. the
corresponding values without exposure to Ang H.
that Ang II inhibits ANP-induced cGMP accumulation in
mesangial cells. The mechanism of this inhibitory effect of Ang
H on ANP-induced cGMP accumulation seems to be different
between in the initial phase and in the maintenance phase of the
action of Ang II.
In the initial phase, it is most likely that the inhibitory effect
of Ang II on ANP-induced cGMP accumulation is due to the
activation of cyclic nucleotide phosphodiesterase because of
the following evidence: first, inhibition was observed in short-
term co-incubation with Ang II and ANP in the absence of
IBMX. Secondly, the accumulation of cGMP induced by so-
dium nitroprusside, an activator of soluble guanylate cyclase,
was also inhibited by one minute exposure to Ang II. Finally,
the treatment of the cells with IBMX prior to the addition of
Ang II and ANP was able to prevent the inhibitory effect of Ang
II on ANP-induced cGMP accumulation in a dose dependent
manner of IBMX, and the inhibition was completely abolished
in the concentrations of IBMX more than 1 mM. A similar
conclusion has been reported in cultured vascular smooth
muscle cells, which were incubated with Ang II and ANP for
one minute [15]. Basal cGMP levels were slightly reduced by
Ang II, though not to a statistically significant degree. This is,
again, similar to the results reported in cultured vascular
smooth muscle cells [15]. The mechanism of the regulation of
cyclic nucleotide phosphodiesterase activity in the unstimu-
lated state might need to be studied further.
Ang II is known to activate phospholipase C after binding to
specific cell surface receptors and, thus, generate inositol-
trisphosphate and diacylglycerol resulting in the elevation of
cytosolic Ca2 and activation of protein kinase C in glomerular
mesangial cells [4, 26, 27]. The elevation of intracellular calcium
seems to be important in the initial phase of the action of Ang II
because the omission of extracellular calcium reduced the
inhibitory effect of Ang II on ANP-induced cGMP accumulation
and A23 187, a calcium ionophore, could mimic the effect of Ang
0—
AngII(M) 0
TPA(M) 0 0 0 10 1O
H7(M) 0 0 i0 0 i0
Fig. 7. Inhibitory effect of Ang II on particulate guanylate cyclase of
cultured mesangial cells activated by ANP. A. Cells (at passage 5) were
first treated with H7 for 20 minutes and then exposed to Ang H for 15
minutes. Particulate fractions were then isolated and basal (LI) and
ANP-stimulated (E) guanylate cyclase activities were measured.
Values shown are mean SEM (N = 4). < 0.05, **P < 0.01 vs.
ANP-stimulated guanylate cyclase activity in the cells which were not
exposed to Ang II. *p < 0.05 vs. basal guanylate cyclase activity in the
cells which were treated with H7 but not exposed to Ang II. B. Cells (at
passage 5) were first treated with H7 for 20 minutes and then exposed
to Ang 11 or TPA for 15 minutes. Particulate fractions were then isolated
and ANP-stimulated guanylate cyclase activity was measured. Values
shown are mean SEM (N = 4). < 0.01 vs. the other three groups.
II. Furthermore, the data that W7, an inhibitor of calmodulin,
reduced the inhibitory effect of Ang II on ANP-induced cGMP
accumulation strongly indicates that calcium dependent, cal-
modulin-stimulated cyclic nucleotide phosphodiesterase could
be activated by Ang II in the initial phase. Although W7 in its
higher concentrations (1O— M) inhibited ANP-induced cGMP
accumulation, the reduction of the inhibitory effect of Ang II
was observed in a dose dependent fashion of W7. Similar
inhibitory effect of W7 on ANP-induced cGMP accumulation
has been reported in isolated mouse Leydig cells, in which
several calmodulin inhibitors including W7 inhibited ANP-
induced cGMP accumulation in the presence of IBMX and W7
showed this inhibitory effect in the concentrations more than 5
x 1Q M [28]. Since these calmodulin inhibitors did not inhibit
particulate guanylate cyclase directly in particulate fractions of
cultured mouse Leydig cells [28], calmodulin inhibitors might
inhibit particulate guanylate cyclase in the intact cells indirectly
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through the changes in some cytoskeletal functions. In contrast
to W7, H7 failed to prevent the inhibitory effect of Ang II on
ANP-induced cGMP accumulation in short term incubation and
TPA could not inhibit ANP-induced cGMP accumulation. Since
TPA has been reported to activate protein kinase C within 30
seconds of exposure [29], one minute incubation will be enough
to activate protein kinase C.
On the other hand, in the maintenance phase, Ang II seems to
inhibit guanylate cyclase through the activation of protein
kinase C, since IBMX failed to inhibit the effect of Ang II in 15
minutes of incubation, and pretreatment of the cells with H7
prevented the inhibitory effect of Ang II on ANP-induced
cGMP accumulation. Moreover, TPA, when exposed to the
cells for 15 minutes, could inhibit ANP-induced cGMP accu-
mulation. Similar inhibition by vasopressin has been reported in
an established smooth muscle cell line [30]. To prove this
hypothesis, we measured the activity of particulate guanylate
cyclase in the membrane fraction isolated from the cells incu-
bated with Ang II or TPA. The activation of particulate guanyl-
ate cyclase by ANP was significantly inhibited when the cells
were treated with Ang II or TPA. This inhibition by Ang 11 or
TPA was prevented by H7. Similar results have been reported
in adrenocortical carcinoma cells, which were pretreated with
phorbol 12- myristate 13-acetate (PMA) for 10 minutes prior to
the isolation of particulate fractions [31]. Therefore, it might be
a general phenomenon that the activation of protein kinase C
results in the inhibition of particulate guanylate cyclase acti-
vated by ANP. However, participation of calcium in the inhi-
bition of guanylate cyclase needs to be considered because
addition of calcium to membrane fraction of cultured mesangial
cells has been reported to inhibit membrane-bound guanylate
cyclase activity stimulated by ANP [32], though the concentra-
tions of calcium used in that experiment seem to be extremely
higher than the concentrations of intracellular calcium.
It is likely that Ang II inhibits ANP-induced cGMP accumu-
lation through two different mechanisms: the activation of
calcium-dependent, calmodulin-stimulated cyclic nucleotide
phosphodiesterase in the initial phase and the inhibition guanyl-
ate cyclase probably due to the activation of protein kinase C in
the maintenance phase.
Glomerular mesangial cells have been considered to contrib-
ute to the regulation of glomerular filtration rates (GFR) by
changing ultrafiltration coefficient (Kf) through their contractil-
ity. Ang II has been reported to reduce Kf by contracting the
mesangial cells [8], while ANP has been reported to increase Kf
by relaxing them [9]. Since both peptides exist simultaneously
in the serum, the interactions between them in glomerular
mesangial cells might be important in the regulation of their
contractility. Indeed, ANP has been reported to inhibit Ang
Il-induced contraction of isolated glomeruli as well as cultured
mesangial cells [10]. Inversely, the present results indicate that
Ang II could not only induce contraction of mesangial cells by
itself, but also inhibit relaxation of mesangial cells induced by
ANP. Although the contractile response of the mesangial cells
was not measured in the present study, cellular cGMP has been
reported to mediate the decrease in cell tonus in response to
ANP [7]. It is, therefore, possible that these two peptides could
counteract each other on the level of glomerular mesangial cells
and, thus, contribute to the regulation of GFR, though direct
measurement of GFR and Kf will be necessary to prove this
hypothesis. In the present study, Ang II inhibited ANP-induced
cGMP accumulation in both initial phase (1 mm) and mainte-
nance phase (longer than 10 mm) through different mechanisms.
Since the contraction or relaxation of the mesangial cells or
glomeruli has been reported to be several minutes after the
exposure to the peptide and continue for 30 to 60 minutes [7, 10,
33, 34], both mechanisms of the effect of Ang II might operate
in inhibiting ANP-induced mesangial cell relaxation.
Reprint requests to Masakazu Haneda, M.D., The Third Department
of Medicine, Shiga University of Medical Science, Seta, Otsu, Shiga
520-21, Japan.
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